Cutler Group LP Karuna Therapeutics, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$161.01 - $317.85 $48,303 - $95,355	300 New	300 $94,000
Q3 2022 Oct 25, 2022	BUY	$123.79 - $277.42 $102,126 - $228,871	825 New	825 $185,000
Q1 2021 Apr 26, 2021	SELL	$95.46 - $133.08 $84,959 - $118,441	-890 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$75.23 - $109.23 $46,567 - $67,613	619 Added 228.41%	890 $90,000
Q3 2020 Oct 27, 2020	SELL	$71.31 - $109.74 $23,460 - $36,104	-329 Reduced 54.83%	271 $20,000
Q2 2020 Jul 22, 2020	SELL	$62.14 - $117.21 $366,874 - $692,007	-5,904 Reduced 90.77%	600 $66,000
Q1 2020 May 07, 2020	BUY	$60.41 - $115.92 $392,906 - $753,943	6,504 New	6,504 $468,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.